Business Context and Reporting Period
Company: UPEXI, INC.
Filing Type: Form 8-K (Current Report)
Date of Report: July 15, 2025
Reporting Period: Event date of July 15, 2025
Business Context: The Company, an emerging growth company incorporated in Delaware, announced the closing of a private placement equity offering.
Key Financial Metrics
Capital Raised: Approximately $50 million in aggregate gross proceeds.
Shares Issued: 12,457,186 shares of common stock.
Offering Price: $4.00 per share for general investors; $4.94 per share for management and board participation.
Participants: Accredited investors, qualified purchasers, institutional investors, CEO Allan Marshall, and Director Gene Salkind.
Other Metrics: The filing does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity positions.
Material Changes
This filing reports a discrete capital event rather than a comparative financial period. The primary material change is the increase in outstanding common stock by 12,457,186 shares and the infusion of approximately $50 million in gross capital. No prior comparable period financial data is included in this specific 8-K report.
Guidance, Outlook, and Risks
Management Commentary: The Company issued a press release (Exhibit 99.1) detailing the closing of the offering. The filing notes that the information provided is furnished and not deemed "filed" for purposes of Section 18 of the Exchange Act, nor incorporated by reference except as expressly set forth.
Outlook: The filing text does not provide specific forward-looking guidance, risk factors, or contingencies beyond the details of the equity offering.
Unusual Items: The offering included participation by the CEO and a Director at a premium price ($4.94) compared to the general offering price ($4.00).
Investor Verification Checklist
- Verify the net proceeds after deducting placement agent fees and offering expenses, as only gross proceeds ($50 million) are stated.
- Review the full text of the press release (Exhibit 99.1) for details on the intended use of proceeds.
- Confirm the updated total share count and potential dilution impact on existing shareholders.
- Check subsequent filings for the final allocation of shares between general investors and management.